Abou MAA, Eltahir YM, Ali AS (2009). Seroprevalence of Hepatitis B virus and Hepatitis C virus among blood donors in Nyala, South Dar Fur, Sudan. J. Virol. 6:146.
Crossref

Afolabi AY, Abraham A, Oladipo EK, Adefolarin AO, Fagbami AH (2013). Transfusion transmissible viral infections among potential blood donors Ibadan, Nigeria. Afr. J.CLN. Exp. Microbial. 14(2):84-87.

Al-Gani FA (2011). Prevalence of HBV, HCV and HIV-1, 2 infections among blood donors in Prince Rashed Ben Al-Hassan Hospital in North Region of Jordan. Int. J. Biol. Med. Res. 2(4):912-916.

Al-Juboury AWF, Salih HALM, AL-Assadi MK, Ali AM (2010). Seroprevalence of Hepatitis B and C among Blood Donors in Babylon Governorate-Iraq. Med. J. Babylon 7(1-2):1-9.

Al-Waleedi AA, Khader YS (2012). Prevalence of hepatitis B and C infections and associated factors among blood donors in Aden city, Yemen. East Mediterr. Health J. 18(6):624-629.

Assefa A, Mathewos B, Alemu A, Addis Z, Alem M, Gizachew M (2013). Hepatitis B and C viral infection among blood donors at Bahir Dar, Ethiopia. Int. J. Med. Res. Health. Sci. 2(3):624-630.

Awole M, Gebre-Selassie S (2005). Seroprevalence of HBsAg and its risk factors among pregnant women in Jimma, Southwest Ethiopia. Ethiop. J. Health Dev. 19(1):45-50.

Communicable Disease Control (2014). Progress toward Prevention of Transfusion-Transmitted Hepatitis B and Hepatitis C Infection-Sub-Saharan Africa, 2000-2011. MMWR 63(29):613-641.

Dessie A, Abera B, Wale F (2007). Seroprevalence of major blood-borne infections among blood donors at Felege Hiwot referral hospital, northwest Ethiopia. Ethiop. J. Health Dev. 21(1):68-69.

Dhruva GA, Agravat AM, Dalsania JD, Katara AA, Dave RG (2014). Transfusion Transmitted Diseases/Infections among Blood donors in a Tertiary Care Hospital at Rajkot, Gujrat, India. Int. Res. J. Med. Sci. 2(4):16-19.

Gelaw B, Mengistu Y (2007). The prevalence of HBV, HCV and malaria parasites among blood donors in Amhara and Tigray regional states. Ethiop. J. Health Dev. 22(1):3-7.

Hanafiah KM, Groeger J, Flaxman AD, Wiersma ST (2013). Global Epidemiology of Hepatitis C Virus Infection: New Estimates of Age-Specific Antibody to HCV Seroprevalence. Hepatolology 57:1333-1342.
Crossref

Lee MH, Yang HI, Yuan Y, L'Italien G, Chen CJ (2014). Epidemiology and natural history of hepatitis C virus infection. World J. Gastroenterol. 20(28):9270-9280.

Nwankwo E, Momodu I, Umar I, Musa B, Adeleke S (2012). Seroprevalence of major blood- borne infections among blood donors Kano, Nigeria. Turk J. Med. Sci. 42(2):337-341.

Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP (2006).The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J. Hepatol. 45(4):529-538.
Crossref

Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP (2006). Epidemiology of Hepatitis B Virus Infection. Epidemiol Rev. 28:112-125.
Crossref

Shittu MO, Adekola SA, Ajao KO, Adeniji TW, Awe CO (2014). Seroprevalence of Hepatitis B Surface Antigenemia and Hepatitis C Virus among Intending Blood Donors at Mother and Child Hospital, Akure, Nigeria. Int. J. Med. Med. Sci. 47(2):1554-1557.

Shrestha AC, Ghimre P, Tiwari BR, Rajkarnikar M (2009). Transfusion-transmissible infections among blood donors in Kathmandu. J. Infect. Dev. Ctries 3(10):794-797.
Crossref

Stokx J, Gillet P, De Weggheleire A, Casas EC, Maendaenda R, Beulane AJ, Jani IV, Kidane S, Mosse CD, Jacobs J, Bottieau E (2011). Seroprevalence of transfusion transmissible infections and evaluation of the pre-donation screening performance at the Provincial Hospital of Tete, Mozambique. BMC Infect. Dis. 11(141):1-8.
Crossref

Viet L, Lan NTN, Ty PX, Björkvoll B, Hoel H, Tore Gutteberg T, et al (2012). Prevalence of hepatitis B & hepatitis C virus infections in potential blood donors in rural Vietnam. Indian J. Med. Res. 136:74-81.

World Health Organization (WHO) (2001). Blood Transfusion Service: Global database on blood safety from 1998-1991. Geneva, WHO/BTS. Summary report.

World Health Organization (WHO) (2009). Executive Board Viral hepatitis Report by the Secretariat. EB126/15, Available at: 

View

World Health Organization (WHO) (2012). Prevention & Control of Viral Hepatitis Infection: Framework for Global Action. Available at: 

View

Yami A, Alemseged F, Hassen A (2011). Hepatitis B and C virus infections and their association with Human immunodeficiency: Across sectional study among blood donors in Ethiopia. Ethiop. J. Health Sci. 21(1):67-75.
Crossref

Zenebe Y, Mulu W, Yimer M, Abera B (2014). Sero-prevalence and risk factors of hepatitis B virus and human immunodeficiency virus infection among pregnant women in Bahir Dar city, Northwest Ethiopia: a cross sectional study. BMC Infect. Dis. 14:118.
Crossref